OpenVSafe by OpenVAERS
Search V-safe

3C5-11656-17378

3 vaccinations 11 coded responses 25 check-ins 11 free-text entries 1 call case
Sex
Female
Age at first dose
36-40
ZIP prefix
633 / MO
Registered
2021-03-10
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-10
    Registered in v-safe
  2. 2021-03-10
    Dose 1 — Pfizer-BioNTech
  3. 2021-03-10
    Health check-in — day 0, dose 1
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  4. 2021-03-11
    Survey response — days 1–6 daily, dose 1
    MedDRA: Oropharyngeal pain — Feeling: Good · Fatigue or tiredness
    Free text: Sore throat when waking up
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2021-03-12
    Survey response — days 1–6 daily, dose 1
    MedDRA: Vision blurred — Feeling: Good
    Free text: Blurry vision
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2021-03-13
    Survey response — days 1–6 daily, dose 1
    MedDRA: Vision blurred — Feeling: Good
    Free text: Blurry vision
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  7. 2021-03-14
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-03-15
    Survey response — days 1–6 daily, dose 1
    MedDRA: Eye complication associated with device, Vision blurred — Feeling: Good
    Free text: Blurry vision with contacts and contact discomfort since receiving the vaccine
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  9. 2021-03-16
    Survey response — days 1–6 daily, dose 1
    MedDRA: Vision blurred — Feeling: Good
    Free text: Blurry vision with contacts and contact discomfort since receiving the vaccine
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  10. 2021-03-17
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  11. 2021-03-24
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  12. 2021-03-31
    Dose 2 — Pfizer-BioNTech
  13. 2021-03-31
    Survey response — day 0, dose 2
    MedDRA: Pruritus, Vision blurred — Feeling: Fair · Site: Pain · Fatigue or tiredness, Nausea
    Free text: Blurry vision, all over itching
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  14. 2021-04-01
    Survey response — days 1–6 daily, dose 2
    MedDRA: Dry eye, Vision blurred — Feeling: Good · Site: Pain
    Free text: Blurry vision with contacts, dry eyes
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  15. 2021-04-03
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  16. 2021-04-04
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  17. 2021-04-05
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  18. 2021-04-06
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  19. 2021-04-09
    Survey response — day 7, dose 2
    MedDRA: Vision blurred — Feeling: Good · Be unable to do your normal daily activities
    Free text: Blurry vision with contacts
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  20. 2021-04-14
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-04-23
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-04-28
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-05-05
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-05-12
    Survey response — day 42, dose 2
    MedDRA: Asthenia, Cough, Fatigue, Sinus disorder — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Cough, sinus issues, fatigue, weakness for the past week.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  25. 2021-07-03
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  26. 2021-09-29
    Survey response — 6 months, dose 2
    MedDRA: C-reactive protein increased, Platelet count increased — Feeling: Good
    Free text: High C-reactive protein and high platelet count in blood test
    MedDRA releases: 2024-11 · check-in free text available
  27. 2021-11-26
    Dose 3 — Pfizer-BioNTech
  28. 2022-03-31
    Health check-in — 12 months, dose 2
    Feeling: Good
    Adult check-in
  29. 2022-11-28
    Survey response — 12 months, dose 3
    MedDRA: Cough, Fatigue, Oropharyngeal pain, Rhinorrhoea, SARS-CoV-2 test positive — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Tested positive to Covid on 8/31/22. Mild symptoms: sore throat, cough, runny nose, fatigue
    MedDRA releases: 2024-11 · check-in free text available
  30. 2022-11-28
    Report sent to call center — 12 months, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  31. 2022-11-29

Vaccinations

DoseDateManufacturerCo-administered
12021-03-10Pfizer-BioNTech
22021-03-31Pfizer-BioNTech
32021-11-26Pfizer-BioNTech No

Call center

1 call center case

1 unsuccessful

See the call center timeline

Free text

Release 5 — days 1–6 daily, dose 1

2021-03-11

Systemic reaction (other): Sore throat when waking up

2021-03-12

Systemic reaction (other): Blurry vision

2021-03-13

Systemic reaction (other): Blurry vision

2021-03-15

Systemic reaction (other): Blurry vision with contacts and contact discomfort since receiving the vaccine

2021-03-16

Systemic reaction (other): Blurry vision with contacts and contact discomfort since receiving the vaccine

Release 6 — day 0, dose 2

2021-03-31

Systemic reaction (other): Blurry vision, all over itching

Release 6 — days 1–6 daily, dose 2

2021-04-01

Systemic reaction (other): Blurry vision with contacts, dry eyes

Release 7 — day 7, dose 2

2021-04-09

Systemic reaction (other): Blurry vision with contacts

Release 8 — day 42, dose 2

2021-05-12

Symptoms: Cough, sinus issues, fatigue, weakness for the past week.

Release 9 — 6 months, dose 2

2021-09-29

Symptoms: High C-reactive protein and high platelet count in blood test

Release 12 — 12 months, dose 3

2022-11-28

Symptoms: Tested positive to Covid on 8/31/22. Mild symptoms: sore throat, cough, runny nose, fatigue

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAsthenia ✓ ✓ ✓
SDC-reactive protein increased · · ✓
SDCough ✓ ✓ ✓
SDFatigue ✓ ✓ ✓
SDOropharyngeal pain · · ✓
SDPlatelet count increased · · ✓
SDRhinorrhoea · · ✓
SDSARS-CoV-2 test positive · · ✓
SDSinus disorder ✓ ✓ ✓
SRODry eye ✓ ✓ ✓
SROEye complication associated with device ✓ ✓ ✓
SROOropharyngeal pain ✓ ✓ ✓
SROPruritus ✓ ✓ ✓
SROVision blurred ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…